Sarepta Therapeutics
SRPT
#4367
Rank
โ‚น215.06 B
Marketcap
โ‚น2,052
Share price
4.49%
Change (1 day)
-80.85%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) Fails to deliver data

Key failure to deliver metrics for Sarepta Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Sarepta Therapeutics (SRPT) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Sarepta Therapeutics (SRPT) - since 2013

Volume in USD (price x number of shares), data since 2013

Sarepta Therapeutics (SRPT) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚น18.17 M-56.69%
2024โ‚น41.97 M24.73%
2023โ‚น33.65 M66.59%
2022โ‚น20.2 M-64.04%
2021โ‚น56.17 M-40.62%
2020โ‚น94.6 M-66.33%
2019โ‚น0.28 B16.72%
2018โ‚น0.24 B253.79%
2017โ‚น68.05 M-40.35%
2016โ‚น0.11 B190.97%
2015โ‚น39.21 M-69.48%
2014โ‚น0.12 B79.12%
2013โ‚น71.71 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Gilead Sciences
GILD
โ‚น60.15 Mโ‚น0.26 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น15.95 Mโ‚น65.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚น21.53 Mโ‚น35.82 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น0.58 Mโ‚น4.51 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น13.72 Mโ‚น39.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น3.49 Mโ‚น32.41 M๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
โ‚น13.55 Mโ‚น56.87 M๐Ÿ‡บ๐Ÿ‡ธ USA